Analyst Research

Report Title Price
Provider: New Constructs, LLC
$25.00
Provider: Wright Reports
$75.00
Provider: Pechala's Reports
$25.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Tandem Diabetes Care Inc Announces Closing Of Initial Public Offering


Tuesday, 19 Nov 2013 04:30pm EST 

Tandem Diabetes Care, Inc announced that the closing of its initial public offering of 9,200,000 shares of common stock at a price of $15.00 per share, which includes the exercise in full by the underwriters of their option to purchase up to an additional 1,200,000 shares. All of the shares in the offering were offered by Tandem. Tandem's common stock is listed on the NASDAQ Global Market under the ticker symbol "TNDM." BofA Merrill Lynch and Piper Jaffray acted as joint book-running managers for the offering. Deutsche Bank Securities and Stifel acted as co-managers. 

Company Quote

12.6
-0.09 -0.71%
6 Feb 2012